Order Article Reprints

Toutounchi NS, Braber S, Hogenkamp A, Varasteh S, Cai Y, Wehkamp T, Tims S, Leusink-Muis T, van Ark I, Wiertsema S, et al. Human Milk Oligosaccharide 3′-GL Improves Influenza-Specific Vaccination Responsiveness and Immunity after Deoxynivalenol Exposure in Preclinical Models. Nutrients. 2021; 13(9):3190. https://doi.org/10.3390/nu13093190

Toutounchi, Negisa Seyed, Saskia Braber, Astrid Hogenkamp, Soheil Varasteh, Yang Cai, Tjalling Wehkamp, Sebastian Tims, Thea Leusink-Muis, Ingrid van Ark, Selma Wiertsema, and et al. 2021. "Human Milk Oligosaccharide 3′-GL Improves Influenza-Specific Vaccination Responsiveness and Immunity after Deoxynivalenol Exposure in Preclinical Models" Nutrients 13, no. 9: 3190. https://doi.org/10.3390/nu13093190

Toutounchi, N. S., Braber, S., Hogenkamp, A., Varasteh, S., Cai, Y., Wehkamp, T., Tims, S., Leusink-Muis, T., van Ark, I., Wiertsema, S., Stahl, B., Kraneveld, A. D., Garssen, J., Folkerts, G., & van’t Land, B. (2021). Human Milk Oligosaccharide 3′-GL Improves Influenza-Specific Vaccination Responsiveness and Immunity after Deoxynivalenol Exposure in Preclinical Models. Nutrients, 13(9), 3190. https://doi.org/10.3390/nu13093190